25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

RTALB (RTA Laboratuvarlari Biyolojik) Stock Analysis
Buy, Hold or Sell?

Let's analyze RTA Laboratuvarlari Biyolojik together

I guess you are interested in RTA Laboratuvarlari Biyolojik. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

  • 📊 Fundamental Analysis (FA) – RTA Laboratuvarlari Biyolojik’s Financial Insights
  • 📈 Technical Analysis (TA) – RTA Laboratuvarlari Biyolojik’s Price Targets

I'm going to help you getting a better view of RTA Laboratuvarlari Biyolojik. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about RTA Laboratuvarlari Biyolojik

I send you an email if I find something interesting about RTA Laboratuvarlari Biyolojik.

1. Quick Overview

1.1. Quick analysis of RTA Laboratuvarlari Biyolojik (30 sec.)










1.2. What can you expect buying and holding a share of RTA Laboratuvarlari Biyolojik? (30 sec.)

How much money do you get?

How much money do you get?
₺0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
₺4.25
Expected worth in 1 year
₺5.47
How sure are you?
87.5%

+ What do you gain per year?

Total Gains per Share
₺1.23
Return On Investment
33.0%

For what price can you sell your share?

Current Price per Share
₺3.71
Expected price per share
₺3 - ₺6.512
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of RTA Laboratuvarlari Biyolojik (5 min.)




Live pricePrice per Share (EOD)
₺3.71
Intrinsic Value Per Share
₺-1.53 - ₺5.62
Total Value Per Share
₺2.72 - ₺9.87

2.2. Growth of RTA Laboratuvarlari Biyolojik (5 min.)




Is RTA Laboratuvarlari Biyolojik growing?

Current yearPrevious yearGrowGrow %
How rich?$51.4m$33.1m$10.7m24.6%

How much money is RTA Laboratuvarlari Biyolojik making?

Current yearPrevious yearGrowGrow %
Making money$1.3m-$1.7m$3.1m226.4%
Net Profit Margin103.5%-207.5%--

How much money comes from the company's main activities?

2.3. Financial Health of RTA Laboratuvarlari Biyolojik (5 min.)




2.4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#393 / 853

Most Revenue
#452 / 853

Most Profit
#133 / 853
3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of RTA Laboratuvarlari Biyolojik?

Welcome investor! RTA Laboratuvarlari Biyolojik's management wants to use your money to grow the business. In return you get a share of RTA Laboratuvarlari Biyolojik.

First you should know what it really means to hold a share of RTA Laboratuvarlari Biyolojik. And how you can make/lose money.

Speculation

The Price per Share of RTA Laboratuvarlari Biyolojik is ₺3.71. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of RTA Laboratuvarlari Biyolojik.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in RTA Laboratuvarlari Biyolojik, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is ₺4.25. Based on the TTM, the Book Value Change Per Share is ₺0.31 per quarter. Based on the YOY, the Book Value Change Per Share is ₺0.40 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is ₺0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of RTA Laboratuvarlari Biyolojik.

How much money are you going to get?

 MRQTTMYOY3Y5Y10Y
 % of Price per Share% of Price per Share% of Price per Share% of Price per Share% of Price per Share% of Price per Share
Usd Eps0.000.1%0.000.1%0.00-0.1%0.000.0%0.000.0%0.000.0%
Usd Book Value Change Per Share0.010.3%0.010.2%0.010.3%0.010.2%0.000.1%0.000.1%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.010.3%0.010.2%0.010.3%0.010.2%0.000.1%0.000.1%
Usd Price Per Share0.07-0.22-0.34-0.26-0.39-0.28-
Price to Earnings Ratio3.88-13.87--16.71-3.90-69.14-532.58-
Price-to-Total Gains Ratio6.89-72.07-22.06-32.68-227.31-315.96-
Price to Book Ratio0.67-2.70-5.61-5.20-26.53-41.50-
Price-to-Total Gains Ratio6.89-72.07-22.06-32.68-227.31-315.96-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.089782
Number of shares11138
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.010.00
Usd Total Gains Per Share0.010.00
Gains per Quarter (11138 shares)82.6053.73
Gains per Year (11138 shares)330.42214.90
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
103303200215205
206616500430420
309919800645635
40132213100860850
5016521640010751065
6019821970012891280
7023132300015041495
8026432630017191710
9029742960019341925
10033043290021492140

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share3.01.00.075.0%8.04.00.066.7%16.04.00.080.0%33.06.01.082.5%41.06.01.085.4%
Book Value Change Per Share4.00.00.0100.0%10.02.00.083.3%18.02.00.090.0%35.05.00.087.5%42.05.01.087.5%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%0.00.040.00.0%0.00.048.00.0%
Total Gains per Share4.00.00.0100.0%10.02.00.083.3%18.02.00.090.0%35.05.00.087.5%42.05.01.087.5%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of RTA Laboratuvarlari Biyolojik compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-3Y+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.4140.306+35%0.400+3%0.281+47%0.199+108%0.104+297%
Book Value Per Share--4.2493.629+17%2.738+55%2.540+67%1.749+143%0.935+354%
Current Ratio--2.2381.287+74%2.225+1%2.161+4%2.103+6%2.837-21%
Debt To Asset Ratio--0.0460.096-52%0.147-68%0.136-66%0.171-73%0.165-72%
Debt To Equity Ratio--0.0490.108-55%0.188-74%0.167-71%0.270-82%0.234-79%
Dividend Per Share----0%-0%-0%-0%-0%
Enterprise Value--1321494598.0004284232182.500-69%6787654156.750-81%5169375044.833-74%7988000587.850-83%5700992880.301-77%
Eps--0.1840.115+59%-0.146+180%0.048+280%0.052+252%0.029+538%
Ev To Sales Ratio--6.62824.875-73%43.805-85%160.243-96%115.376-94%100.876-93%
Free Cash Flow Per Share--0.037-0.121+429%-0.074+301%-0.070+290%-0.051+239%-0.028+177%
Free Cash Flow To Equity Per Share--0.037-0.121+429%-0.074+301%-0.071+293%-0.043+217%-0.021+158%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%0.975+3%
Intrinsic Value_10Y_max--5.619----------
Intrinsic Value_10Y_min---1.529----------
Intrinsic Value_1Y_max---0.015----------
Intrinsic Value_1Y_min---0.259----------
Intrinsic Value_3Y_max--0.396----------
Intrinsic Value_3Y_min---0.691----------
Intrinsic Value_5Y_max--1.338----------
Intrinsic Value_5Y_min---1.025----------
Market Cap1855000000.000+23%1425000000.0004472500000.000-68%7032500000.000-80%5354583333.333-73%8142000000.000-82%5784248924.076-75%
Net Profit Margin--1.8411.035+78%-2.075+213%6.566-72%4.179-56%2.185-16%
Operating Margin----0%-0%-1.2460%-0.6500%-0.3080%
Operating Ratio--1.7611.894-7%2.388-26%3.562-51%2.649-34%2.055-14%
Pb Ratio0.873+23%0.6712.698-75%5.606-88%5.197-87%26.534-97%41.505-98%
Pe Ratio5.054+23%3.88313.869-72%-16.713+530%3.8960%69.136-94%532.582-99%
Price Per Share3.710+23%2.8508.945-68%14.065-80%10.709-73%16.284-82%11.532-75%
Price To Free Cash Flow Ratio25.339+23%19.466-13.185+168%25.936-25%3.848+406%-13.387+169%-198.785+1121%
Price To Total Gains Ratio8.967+23%6.88972.071-90%22.058-69%32.682-79%227.308-97%315.964-98%
Quick Ratio--1.0580.547+94%0.755+40%0.978+8%1.029+3%1.342-21%
Return On Assets--0.0410.025+68%-0.061+247%0.027+52%0.051-18%0.038+7%
Return On Equity--0.0430.026+64%-0.082+289%0.030+42%0.064-32%0.049-12%
Total Gains Per Share--0.4140.306+35%0.400+3%0.281+47%0.199+108%0.104+297%
Usd Book Value--51409819.14643913573.513+17%33129212.981+55%30738485.297+67%21159977.621+143%11328853.077+354%
Usd Book Value Change Per Share--0.0100.007+35%0.010+3%0.007+47%0.005+108%0.003+297%
Usd Book Value Per Share--0.1030.088+17%0.066+55%0.061+67%0.042+143%0.023+354%
Usd Dividend Per Share----0%-0%-0%-0%-0%
Usd Enterprise Value--31980169.272103678418.817-69%164261230.593-81%125098876.085-74%193309614.226-83%137964027.703-77%
Usd Eps--0.0040.003+59%-0.004+180%0.001+280%0.001+252%0.001+538%
Usd Free Cash Flow--442898.962-1458749.991+429%-890054.486+301%-843347.083+290%-615702.896+239%-316274.808+171%
Usd Free Cash Flow Per Share--0.001-0.003+429%-0.002+301%-0.002+290%-0.001+239%-0.001+177%
Usd Free Cash Flow To Equity Per Share--0.001-0.003+429%-0.002+301%-0.002+293%-0.001+217%-0.001+158%
Usd Market Cap44891000.000+23%34485000.000108234500.000-68%170186500.000-80%129580916.667-73%197036400.000-82%139978823.963-75%
Usd Price Per Share0.090+23%0.0690.216-68%0.340-80%0.259-73%0.394-82%0.279-75%
Usd Profit--2220381.5081397410.402+59%-1766005.122+180%583562.676+280%631111.962+252%348684.551+537%
Usd Revenue--1206210.2071124959.573+7%997735.327+21%807752.017+49%1217943.703-1%732536.173+65%
Usd Total Gains Per Share--0.0100.007+35%0.010+3%0.007+47%0.005+108%0.003+297%
 EOD+4 -4MRQTTM+27 -8YOY+27 -83Y+26 -95Y+23 -1210Y+24 -12

3.3 Fundamental Score

Let's check the fundamental score of RTA Laboratuvarlari Biyolojik based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-155.054
Price to Book Ratio (EOD)Between0-10.873
Net Profit Margin (MRQ)Greater than01.841
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than11.058
Current Ratio (MRQ)Greater than12.238
Debt to Asset Ratio (MRQ)Less than10.046
Debt to Equity Ratio (MRQ)Less than10.049
Return on Equity (MRQ)Greater than0.150.043
Return on Assets (MRQ)Greater than0.050.041
Total7/10 (70.0%)

3.4 Technical Score

Let's check the technical score of RTA Laboratuvarlari Biyolojik based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5053.767
Ma 20Greater thanMa 503.706
Ma 50Greater thanMa 1003.446
Ma 100Greater thanMa 2003.179
OpenGreater thanClose3.750
Total4/5 (80.0%)

4. In-depth Analysis

4.1 About RTA Laboratuvarlari Biyolojik

RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret A.S. engages in the research, development, and production of microbiology and molecular biology products in Turkey. It offers microbiology products, including petri dish, tube and bottle, chromogenic media, blood culture bottle, tuberculosis diagnostic, rapid test, microbiological stain, hygislide, surcheck media, membrane, and swab products; and molecular biology products, such as nucleic acid isolation kits, real time PCR kits, and voltran viral load detection systems. The company was incorporated in 1996 and is based in Kocaeli, Turkey.

Fundamental data was last updated by Penke on 2025-09-17 01:59:03.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is less efficient in making profit.
Using its investors money, the company is inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is underpriced.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit RTA Laboratuvarlari Biyolojik earns for each ₤1 of revenue.

  • Above 10% is considered healthy but always compare RTA Laboratuvarlari Biyolojik to the Biotechnology industry mean.
  • A Net Profit Margin of 184.1% means that ₤1.84 for each ₤1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of RTA Laboratuvarlari Biyolojik:

  • The MRQ is 184.1%. The company is making a huge profit. +2
  • The TTM is 103.5%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ184.1%TTM103.5%+80.6%
TTM103.5%YOY-207.5%+311.0%
TTM103.5%5Y417.9%-314.4%
5Y417.9%10Y218.5%+199.5%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ184.1%-85.5%+269.6%
TTM103.5%-171.0%+274.5%
YOY-207.5%-210.0%+2.5%
3Y656.6%-289.9%+946.5%
5Y417.9%-381.1%+799.0%
10Y218.5%-520.3%+738.8%
4.3.1.2. Return on Assets

Shows how efficient RTA Laboratuvarlari Biyolojik is using its assets to generate profit.

  • Above 5% is considered healthy but always compare RTA Laboratuvarlari Biyolojik to the Biotechnology industry mean.
  • 4.1% Return on Assets means that RTA Laboratuvarlari Biyolojik generated ₤0.04 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of RTA Laboratuvarlari Biyolojik:

  • The MRQ is 4.1%. Using its assets, the company is less efficient in making profit.
  • The TTM is 2.5%. Using its assets, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ4.1%TTM2.5%+1.7%
TTM2.5%YOY-6.1%+8.5%
TTM2.5%5Y5.1%-2.6%
5Y5.1%10Y3.8%+1.2%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ4.1%-11.9%+16.0%
TTM2.5%-11.9%+14.4%
YOY-6.1%-11.2%+5.1%
3Y2.7%-12.0%+14.7%
5Y5.1%-11.7%+16.8%
10Y3.8%-13.8%+17.6%
4.3.1.3. Return on Equity

Shows how efficient RTA Laboratuvarlari Biyolojik is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare RTA Laboratuvarlari Biyolojik to the Biotechnology industry mean.
  • 4.3% Return on Equity means RTA Laboratuvarlari Biyolojik generated ₤0.04 for each ₤1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of RTA Laboratuvarlari Biyolojik:

  • The MRQ is 4.3%. Using its investors money, the company is inefficient in making profit. -1
  • The TTM is 2.6%. Using its investors money, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ4.3%TTM2.6%+1.7%
TTM2.6%YOY-8.2%+10.8%
TTM2.6%5Y6.4%-3.7%
5Y6.4%10Y4.9%+1.5%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ4.3%-14.2%+18.5%
TTM2.6%-15.2%+17.8%
YOY-8.2%-15.3%+7.1%
3Y3.0%-16.9%+19.9%
5Y6.4%-17.5%+23.9%
10Y4.9%-19.6%+24.5%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of RTA Laboratuvarlari Biyolojik.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient RTA Laboratuvarlari Biyolojik is operating .

  • Measures how much profit RTA Laboratuvarlari Biyolojik makes for each ₤1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare RTA Laboratuvarlari Biyolojik to the Biotechnology industry mean.
  • An Operating Margin of 0.0% means the company generated ₤0.00  for each ₤1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of RTA Laboratuvarlari Biyolojik:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-65.0%+65.0%
5Y-65.0%10Y-30.8%-34.2%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--154.1%+154.1%
TTM--280.2%+280.2%
YOY--268.7%+268.7%
3Y-124.6%-281.5%+156.9%
5Y-65.0%-350.8%+285.8%
10Y-30.8%-530.7%+499.9%
4.3.2.2. Operating Ratio

Measures how efficient RTA Laboratuvarlari Biyolojik is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 1.76 means that the operating costs are ₤1.76 for each ₤1 in net sales.

Let's take a look of the Operating Ratio trends of RTA Laboratuvarlari Biyolojik:

  • The MRQ is 1.761. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.894. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.761TTM1.894-0.133
TTM1.894YOY2.388-0.494
TTM1.8945Y2.649-0.755
5Y2.64910Y2.055+0.594
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.7611.952-0.191
TTM1.8942.974-1.080
YOY2.3883.047-0.659
3Y3.5623.835-0.273
5Y2.6494.924-2.275
10Y2.0556.864-4.809
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of RTA Laboratuvarlari Biyolojik.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if RTA Laboratuvarlari Biyolojik is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 2.24 means the company has ₤2.24 in assets for each ₤1 in short-term debts.

Let's take a look of the Current Ratio trends of RTA Laboratuvarlari Biyolojik:

  • The MRQ is 2.238. The company is able to pay all its short-term debts. +1
  • The TTM is 1.287. The company is just able to pay all its short-term debts.
Trends
Current periodCompared to+/- 
MRQ2.238TTM1.287+0.951
TTM1.287YOY2.225-0.938
TTM1.2875Y2.103-0.816
5Y2.10310Y2.837-0.734
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ2.2383.480-1.242
TTM1.2873.790-2.503
YOY2.2254.104-1.879
3Y2.1614.609-2.448
5Y2.1035.764-3.661
10Y2.8376.154-3.317
4.4.3.2. Quick Ratio

Measures if RTA Laboratuvarlari Biyolojik is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare RTA Laboratuvarlari Biyolojik to the Biotechnology industry mean.
  • A Quick Ratio of 1.06 means the company can pay off ₤1.06 for each ₤1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of RTA Laboratuvarlari Biyolojik:

  • The MRQ is 1.058. The company is just able to pay all its short-term debts with the most liquid assets.
  • The TTM is 0.547. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ1.058TTM0.547+0.512
TTM0.547YOY0.755-0.209
TTM0.5475Y1.029-0.483
5Y1.02910Y1.342-0.312
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.0582.938-1.880
TTM0.5473.291-2.744
YOY0.7553.928-3.173
3Y0.9784.393-3.415
5Y1.0295.837-4.808
10Y1.3426.549-5.207
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of RTA Laboratuvarlari Biyolojik.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of RTA Laboratuvarlari Biyolojik assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare RTA Laboratuvarlari Biyolojik to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.05 means that RTA Laboratuvarlari Biyolojik assets are financed with 4.6% credit (debt) and the remaining percentage (100% - 4.6%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of RTA Laboratuvarlari Biyolojik:

  • The MRQ is 0.046. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.096. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.046TTM0.096-0.050
TTM0.096YOY0.147-0.051
TTM0.0965Y0.171-0.074
5Y0.17110Y0.165+0.006
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0460.339-0.293
TTM0.0960.359-0.263
YOY0.1470.334-0.187
3Y0.1360.341-0.205
5Y0.1710.349-0.178
10Y0.1650.379-0.214
4.5.4.2. Debt to Equity Ratio

Measures if RTA Laboratuvarlari Biyolojik is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare RTA Laboratuvarlari Biyolojik to the Biotechnology industry mean.
  • A Debt to Equity ratio of 4.9% means that company has ₤0.05 debt for each ₤1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of RTA Laboratuvarlari Biyolojik:

  • The MRQ is 0.049. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.108. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.049TTM0.108-0.059
TTM0.108YOY0.188-0.080
TTM0.1085Y0.270-0.162
5Y0.27010Y0.234+0.036
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0490.391-0.342
TTM0.1080.436-0.328
YOY0.1880.436-0.248
3Y0.1670.461-0.294
5Y0.2700.461-0.191
10Y0.2340.514-0.280
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ₤1 in earnings RTA Laboratuvarlari Biyolojik generates.

  • Above 15 is considered overpriced but always compare RTA Laboratuvarlari Biyolojik to the Biotechnology industry mean.
  • A PE ratio of 3.88 means the investor is paying ₤3.88 for every ₤1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of RTA Laboratuvarlari Biyolojik:

  • The EOD is 5.054. Based on the earnings, the company is cheap. +2
  • The MRQ is 3.883. Based on the earnings, the company is cheap. +2
  • The TTM is 13.869. Based on the earnings, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD5.054MRQ3.883+1.172
MRQ3.883TTM13.869-9.986
TTM13.869YOY-16.713+30.582
TTM13.8695Y69.136-55.267
5Y69.13610Y532.582-463.446
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD5.054-2.539+7.593
MRQ3.883-2.361+6.244
TTM13.869-2.657+16.526
YOY-16.713-3.749-12.964
3Y3.896-3.883+7.779
5Y69.136-6.353+75.489
10Y532.582-7.102+539.684
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of RTA Laboratuvarlari Biyolojik:

  • The EOD is 25.339. Based on how much money comes from the company's main activities, the company is underpriced. +1
  • The MRQ is 19.466. Based on how much money comes from the company's main activities, the company is underpriced. +1
  • The TTM is -13.185. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD25.339MRQ19.466+5.874
MRQ19.466TTM-13.185+32.650
TTM-13.185YOY25.936-39.121
TTM-13.1855Y-13.387+0.202
5Y-13.38710Y-198.785+185.398
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD25.339-3.411+28.750
MRQ19.466-2.951+22.417
TTM-13.185-3.614-9.571
YOY25.936-4.421+30.357
3Y3.848-5.258+9.106
5Y-13.387-8.587-4.800
10Y-198.785-9.639-189.146
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of RTA Laboratuvarlari Biyolojik is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 0.67 means the investor is paying ₤0.67 for each ₤1 in book value.

Let's take a look of the Price to Book Ratio trends of RTA Laboratuvarlari Biyolojik:

  • The EOD is 0.873. Based on the equity, the company is cheap. +2
  • The MRQ is 0.671. Based on the equity, the company is cheap. +2
  • The TTM is 2.698. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD0.873MRQ0.671+0.202
MRQ0.671TTM2.698-2.028
TTM2.698YOY5.606-2.907
TTM2.6985Y26.534-23.836
5Y26.53410Y41.505-14.971
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD0.8732.206-1.333
MRQ0.6712.027-1.356
TTM2.6982.194+0.504
YOY5.6062.425+3.181
3Y5.1972.571+2.626
5Y26.5343.805+22.729
10Y41.5054.462+37.043
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Latest Balance Sheet

Balance Sheet of 2025-06-30. Currency in TRY. All numbers in thousands.

Summary
Total Assets2,227,878
Total Liabilities103,505
Total Stockholder Equity2,124,373
 As reported
Total Liabilities 103,505
Total Stockholder Equity+ 2,124,373
Total Assets = 2,227,878

Assets

Total Assets2,227,878
Total Current Assets172,868
Long-term Assets2,055,010
Total Current Assets
Cash And Cash Equivalents 4,899
Short-term Investments 4,691
Net Receivables 77,057
Inventory 30,884
Other Current Assets 2
Total Current Assets  (as reported)172,868
Total Current Assets  (calculated)117,533
+/- 55,335
Long-term Assets
Property Plant Equipment 327,295
Intangible Assets 28
Long-term Assets  (as reported)2,055,010
Long-term Assets  (calculated)327,323
+/- 1,727,687

Liabilities & Shareholders' Equity

Total Current Liabilities77,239
Long-term Liabilities26,267
Total Stockholder Equity2,124,373
Total Current Liabilities
Short Long Term Debt 42,141
Accounts payable 24,266
Other Current Liabilities 25
Total Current Liabilities  (as reported)77,239
Total Current Liabilities  (calculated)66,432
+/- 10,807
Long-term Liabilities
Long term Debt 17,944
Capital Lease Obligations Min Short Term Debt6,738
Long-term Liabilities  (as reported)26,267
Long-term Liabilities  (calculated)24,682
+/- 1,585
Total Stockholder Equity
Retained Earnings 1,142,451
Total Stockholder Equity (as reported)2,124,373
Total Stockholder Equity (calculated)1,142,451
+/- 981,921
Other
Capital Stock500,000
Common Stock Shares Outstanding 500,000
Net Debt 55,185
Net Invested Capital 2,184,457
Net Working Capital 95,630
Property Plant and Equipment Gross 525,539



6.2. Balance Sheets Structured

Currency in TRY. All numbers in thousands.

 Trend2025-06-302025-03-312024-12-312024-09-302024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-03-312012-12-312011-12-312010-12-31
> Total Assets 
16,857
16,604
20,450
0
29,352
29,409
40,368
45,782
49,042
52,462
54,155
54,642
60,756
60,758
61,103
58,354
60,893
64,259
64,076
63,345
63,092
61,439
61,093
62,075
65,640
66,353
71,123
82,008
98,160
127,310
181,568
212,054
256,525
319,067
161,739
501,067
552,404
541,113
558,881
690,060
740,213
735,081
832,569
1,022,946
1,804,552
1,810,062
1,817,726
1,747,855
1,921,167
2,114,613
2,227,878
2,227,8782,114,6131,921,1671,747,8551,817,7261,810,0621,804,5521,022,946832,569735,081740,213690,060558,881541,113552,404501,067161,739319,067256,525212,054181,568127,31098,16082,00871,12366,35365,64062,07561,09361,43963,09263,34564,07664,25960,89358,35461,10360,75860,75654,64254,15552,46249,04245,78240,36829,40929,352020,45016,60416,857
   > Total Current Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
41,317
41,098
40,847
37,917
36,504
36,674
32,864
31,994
14,876
23,621
34,561
59,666
103,684
120,176
142,975
194,043
222,304
323,087
369,387
326,440
297,312
317,029
300,531
288,269
281,423
252,229
249,155
184,419
206,861
184,365
155,035
174,925
172,868
172,868174,925155,035184,365206,861184,419249,155252,229281,423288,269300,531317,029297,312326,440369,387323,087222,304194,043142,975120,176103,68459,66634,56123,62114,87631,99432,86436,67436,50437,91740,84741,09841,317000000000000000000
       Cash And Cash Equivalents 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
13,756
13,037
15,124
13,159
16,142
11,404
6,141
3,561
633
842
12,379
23,057
11,689
1,107
15,662
4,828
52,487
70,121
157,539
71,567
24,028
62,929
31,363
157,120
38,751
88,380
32,664
13,208
13,032
13,116
6,512
6,123
4,899
4,8996,1236,51213,11613,03213,20832,66488,38038,751157,12031,36362,92924,02871,567157,53970,12152,4874,82815,6621,10711,68923,05712,3798426333,5616,14111,40416,14213,15915,12413,03713,756000000000000000000
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
5,326
3,490
9,432
0
0
41
0
0
9,544
3,241
1,372
917
868
264
270
5,863
313
6,731
15,244
118,082
1,147
111,933
50,852
70,096
540
545
541
4,471
4,759
4,691
4,6914,7594,47154154554070,09650,852111,9331,147118,08215,2446,7313135,8632702648689171,3723,2419,5440041009,4323,4905,326000000000000000000000
       Net Receivables 
4,575
4,649
7,204
0
5,509
6,451
6,991
7,574
7,847
8,359
7,443
7,982
9,101
8,988
7,929
7,687
9,872
10,707
12,300
12,656
14,893
9,978
8,539
8,247
18,515
8,713
7,472
6,805
16,310
16,522
31,290
37,277
76,582
134,962
102,746
171,139
141,272
200,247
204,353
169,909
92,770
74,925
55,857
32,798
42,199
45,578
49,165
55,855
60,296
75,152
77,057
77,05775,15260,29655,85549,16545,57842,19932,79855,85774,92592,770169,909204,353200,247141,272171,139102,746134,96276,58237,27731,29016,52216,3106,8057,4728,71318,5158,2478,5399,97814,89312,65612,30010,7079,8727,6877,9298,9889,1017,9827,4438,3597,8477,5746,9916,4515,50907,2044,6494,575
       Other Current Assets 
512
628
863
0
800
553
1,273
1,981
1,419
2,455
1,725
2,168
4,849
3,210
2,685
3,568
2,916
2,504
2,365
2,300
2,410
3,461
1,585
1,893
3,984
2,333
0
4
2,763
6,502
17,173
15,813
21,661
25,266
26,200
26,599
26,584
25,028
33,628
31,067
30,309
17,474
41,203
25
283
11
8
16
3
5
2
253168112832541,20317,47430,30931,06733,62825,02826,58426,59926,20025,26621,66115,81317,1736,5022,763402,3333,9841,8931,5853,4612,4102,3002,3652,5042,9163,5682,6853,2104,8492,1681,7252,4551,4191,9811,2735538000863628512
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
34,359
56,247
58,387
63,600
67,644
77,884
91,878
113,550
125,024
165,259
177,979
183,017
214,673
261,569
373,031
439,682
446,812
551,147
770,717
1,034,798
1,625,643
1,610,866
1,563,490
1,766,132
1,939,688
2,055,010
2,055,0101,939,6881,766,1321,563,4901,610,8661,625,6431,034,798770,717551,147446,812439,682373,031261,569214,673183,017177,979165,259125,024113,55091,87877,88467,64463,60058,38756,24734,3590000000000000000000000000
       Property Plant Equipment 
2,191
1,836
3,237
0
8,061
8,071
8,113
8,467
8,246
9,174
9,679
10,181
9,818
9,954
16,786
16,745
11,616
11,400
9,882
9,523
9,482
9,550
9,651
10,297
11,167
11,444
0
15,116
14,781
15,157
15,714
22,165
31,399
34,636
40,300
43,705
46,754
48,488
48,342
54,149
53,680
49,052
50,636
57,166
146,468
163,535
180,901
226,040
286,325
310,325
327,295
327,295310,325286,325226,040180,901163,535146,46857,16650,63649,05253,68054,14948,34248,48846,75443,70540,30034,63631,39922,16515,71415,15714,78115,116011,44411,16710,2979,6519,5509,4829,5239,88211,40011,61616,74516,7869,9549,81810,1819,6799,1748,2468,4678,1138,0718,06103,2371,8362,191
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,031
1,031
1,031
1,031
1,031
1,031
1,031
1,031
1,031
1,031
1,031
1,031
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000000000001,0311,0311,0311,0311,0311,0311,0311,0311,0311,0311,0311,03100000000000000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
22,891
28,193
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000000028,19322,891000000000000000000000000000
       Intangible Assets 
357
1,047
1,127
0
808
784
682
729
680
1,022
998
998
7,424
7,237
1,145
1,123
1,084
1,080
1,077
1,078
1,088
1,956
2,045
2,394
57
685
610
541
477
498
587
709
760
710
649
620
564
535
506
477
449
164
147
130
302
279
238
191
131
85
28
2885131191238279302130147164449477506535564620649710760709587498477541610685572,3942,0451,9561,0881,0781,0771,0801,0841,1231,1457,2377,4249989981,02268072968278480801,1271,047357
       Long-term Assets Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
34,359
56,247
58,387
63,600
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000000063,60058,38756,24734,3590000000000000000000000000
> Total Liabilities 
5,393
6,412
9,459
0
8,519
7,738
4,645
9,434
11,399
12,452
12,386
11,788
15,279
13,588
11,729
9,768
10,690
12,973
11,875
10,165
8,841
6,470
6,167
7,005
6,955
5,736
6,179
4,849
11,466
28,312
50,418
65,193
88,719
122,529
-77,917
172,491
209,170
158,947
118,357
131,538
107,473
129,956
121,077
113,135
164,132
395,838
306,279
200,292
252,170
197,104
103,505
103,505197,104252,170200,292306,279395,838164,132113,135121,077129,956107,473131,538118,357158,947209,170172,491-77,917122,52988,71965,19350,41828,31211,4664,8496,1795,7366,9557,0056,1676,4708,84110,16511,87512,97310,6909,76811,72913,58815,27911,78812,38612,45211,3999,4344,6457,7388,51909,4596,4125,393
   > Total Current Liabilities 
4,987
6,062
8,963
0
7,043
6,220
3,211
7,541
9,725
10,208
10,047
9,239
10,386
11,406
9,987
8,250
9,278
11,596
10,788
9,316
8,264
6,146
5,682
6,651
6,625
5,425
2,797
1,602
7,808
23,679
45,675
60,418
82,514
116,527
143,165
171,346
204,880
133,905
97,276
110,701
88,585
108,572
94,524
82,683
88,819
127,879
129,150
161,802
215,068
166,682
77,239
77,239166,682215,068161,802129,150127,87988,81982,68394,524108,57288,585110,70197,276133,905204,880171,346143,165116,52782,51460,41845,67523,6797,8081,6022,7975,4256,6256,6515,6826,1468,2649,31610,78811,5969,2788,2509,98711,40610,3869,23910,04710,2089,7257,5413,2116,2207,04308,9636,0624,987
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,492
146
107
67
24
0
0
539
0
88
6,109
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000000006,1098805390024671071461,492000000000000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,492
146
107
67
24
0
0
539
0
88
6,109
9,684
15,123
16,860
21,910
0
835
46,242
55,121
56,552
26,620
67,834
67,076
79,213
71,007
51,226
43,556
14,640
73,672
135,715
188,426
134,050
42,141
42,141134,050188,426135,71573,67214,64043,55651,22671,00779,21367,07667,83426,62056,55255,12146,242835021,91016,86015,1239,6846,1098805390024671071461,492000000000000000000
       Accounts payable 
2,254
3,894
5,234
0
5,530
5,002
1,636
5,063
7,573
8,359
7,528
5,999
6,170
7,781
5,941
5,562
5,902
8,496
7,692
5,918
4,843
3,717
3,565
4,854
5,260
3,893
2,144
1,166
1,438
2,096
16,507
23,184
23,517
50,086
32,282
83,153
101,272
52,326
17,745
16,656
11,149
15,704
12,317
18,981
34,799
30,931
44,261
20,330
20,444
22,184
24,266
24,26622,18420,44420,33044,26130,93134,79918,98112,31715,70411,14916,65617,74552,326101,27283,15332,28250,08623,51723,18416,5072,0961,4381,1662,1443,8935,2604,8543,5653,7174,8435,9187,6928,4965,9025,5625,9417,7816,1705,9997,5288,3597,5735,0631,6365,0025,53005,2343,8942,254
       Other Current Liabilities 
1,791
1,176
2,412
0
1,505
1,162
1,473
2,353
1,897
1,654
2,195
2,995
4,190
1,203
1,750
1,373
1,848
1,197
1,635
1,843
1,935
1,188
323
250
113
260
165
25
83
11,548
13,615
19,846
29,921
18,690
68,734
36,477
45,750
23,972
23,646
23,741
8,796
11,185
9,033
78
0
13
0
0
0
52
25
2552000130789,03311,1858,79623,74123,64623,97245,75036,47768,73418,69029,92119,84613,61511,54883251652601132503231,1881,9351,8431,6351,1971,8481,3731,7501,2034,1902,9952,1951,6541,8972,3531,4731,1621,50502,4121,1761,791
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
311
3,383
3,247
3,657
4,633
4,743
4,775
6,204
6,002
-221,082
1,145
4,289
25,042
21,081
20,837
18,888
21,384
26,554
30,452
75,312
267,959
177,129
38,490
37,102
30,422
26,267
26,26730,42237,10238,490177,129267,95975,31230,45226,55421,38418,88820,83721,08125,0424,2891,145-221,0826,0026,2044,7754,7434,6333,6573,2473,3833110000000000000000000000000
       Capital Lease Obligations Min Short Term Debt
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-1,492
-146
-107
-67
-24
0
0
-539
0
-88
-6,109
0
138
203
985
0
0
632
528
205
991
866
1,183
746
692
636
2,167
2,072
5,259
0
5,480
4,915
6,738
6,7384,9155,48005,2592,0722,1676366927461,183866991205528632009852031380-6,109-880-53900-24-67-107-146-1,492000000000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,156
1,054
954
0
0
0
630
561
0
421
357
301
241
175
104
37
-31
0
0
0
-36
0
0
0
0
0
0
0
0
0
0
0
0
000000000000-36000-313710417524130135742105616300009541,0541,156000000000000000000
> Total Stockholder Equity
11,848
10,991
11,875
10,991
20,833
21,671
35,722
35,480
36,726
39,092
40,974
41,996
44,585
46,377
48,868
48,113
49,922
51,097
52,038
53,067
54,171
54,971
54,903
55,443
59,536
61,316
64,944
77,159
86,628
97,122
123,571
137,623
150,275
174,750
211,461
299,567
312,674
344,920
403,690
521,643
594,521
605,125
711,492
909,810
1,119,821
1,414,224
1,511,448
1,547,563
1,668,997
1,917,509
2,124,373
2,124,3731,917,5091,668,9971,547,5631,511,4481,414,2241,119,821909,810711,492605,125594,521521,643403,690344,920312,674299,567211,461174,750150,275137,623123,57197,12286,62877,15964,94461,31659,53655,44354,90354,97154,17153,06752,03851,09749,92248,11348,86846,37744,58541,99640,97439,09236,72635,48035,72221,67120,83310,99111,87510,99111,848
   Common Stock
4,800
4,800
4,800
0
4,800
4,800
5,900
5,900
5,900
5,900
5,900
5,900
5,900
5,900
5,900
5,900
5,900
5,900
23,600
23,600
23,600
23,600
23,600
23,600
23,600
23,600
0
36,100
36,100
41,000
41,000
41,000
41,000
41,000
41,000
42,970
42,970
42,970
100,000
100,000
100,000
100,000
100,000
0
0
0
0
0
0
0
0
00000000100,000100,000100,000100,000100,00042,97042,97042,97041,00041,00041,00041,00041,00041,00036,10036,100023,60023,60023,60023,60023,60023,60023,60023,6005,9005,9005,9005,9005,9005,9005,9005,9005,9005,9005,9005,9004,8004,80004,8004,8004,800
   Retained Earnings 
5,699
4,454
6,031
0
11,575
12,966
14,070
15,084
16,183
18,273
20,225
22,298
23,971
25,551
25,656
24,971
26,902
28,031
23,371
24,448
25,618
25,655
25,711
26,263
27,774
29,549
31,892
31,504
32,228
41,200
67,675
81,780
93,161
117,642
154,359
194,543
207,634
239,900
272,702
390,637
463,841
474,445
580,812
776,083
536,759
743,716
755,256
755,217
827,200
991,164
1,142,451
1,142,451991,164827,200755,217755,256743,716536,759776,083580,812474,445463,841390,637272,702239,900207,634194,543154,359117,64293,16181,78067,67541,20032,22831,50431,89229,54927,77426,26325,71125,65525,61824,44823,37128,03126,90224,97125,65625,55123,97122,29820,22518,27316,18315,08414,07012,96611,57506,0314,4545,699
   Capital Surplus 000000000000000000000000000000000000000000000000000
   Treasury Stock000000000000000000000000000000000-94-94-94000000000000000
   Other Stockholders Equity 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
5,067
5,019
4,952
5,716
5,593
5,580
8,161
8,168
0
8,084
18,230
7,991
7,964
7,912
9,183
9,177
9,171
9,177
9,192
9,173
9,173
9,191
8,865
8,865
8,865
0
0
0
0
0
0
0
0
000000008,8658,8658,8659,1919,1739,1739,1929,1779,1719,1779,1837,9127,9647,99118,2308,08408,1688,1615,5805,5935,7164,9525,0195,067000000000000000000



6.3. Balance Sheets

Currency in TRY. All numbers in thousands.




6.4. Cash Flows

Currency in TRY. All numbers in thousands.




6.5. Income Statements

Currency in TRY. All numbers in thousands.


6.6. Latest Income Statement

Income Statement (annual), 2024-12-31. Currency in TRY. All numbers in thousands.

Gross Profit (+$)
totalRevenue158,590
Cost of Revenue-116,481
Gross Profit42,10942,109
 
Operating Income (+$)
Gross Profit42,109
Operating Expense-200,795
Operating Income-42,205-158,685
 
Operating Expense (+$)
Research Development22,191
Selling General Administrative16,273
Selling And Marketing Expenses0
Operating Expense200,79538,464
 
Net Interest Income (+$)
Interest Income8,131
Interest Expense-78,003
Other Finance Cost-189
Net Interest Income-70,062
 
Pretax Income (+$)
Operating Income-42,205
Net Interest Income-70,062
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-51,663-42,205
EBIT - interestExpense = -78,003
52,235
130,238
Interest Expense78,003
Earnings Before Interest and Taxes (EBIT)026,341
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax-51,663
Tax Provision--103,898
Net Income From Continuing Ops52,23552,235
Net Income52,235
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net070,062
 

Technical Analysis of RTA Laboratuvarlari Biyolojik
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of RTA Laboratuvarlari Biyolojik. The general trend of RTA Laboratuvarlari Biyolojik is BULLISH with 85.7% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine RTA Laboratuvarlari Biyolojik's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (85.7%) Bearish trend (-85.7%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. RTA Laboratuvarlari Biyolojik Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of RTA Laboratuvarlari Biyolojik.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 4.05 < 4.212 < 6.512.

The bearish price targets are: 3.33 > 3.03 > 3.

Know someone who trades $RTALB? Share this with them.👇

RTA Laboratuvarlari Biyolojik Daily Support & Resistance Chart
3rd party ad coffee SUPPORTERis ad-free.

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of RTA Laboratuvarlari Biyolojik. The current mas is .

The long score for the Moving Averages is 13/14.
The longshort score for the Moving Averages is 12/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

RTA Laboratuvarlari Biyolojik Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of RTA Laboratuvarlari Biyolojik. The current macd is 0.03475744.

The long score for the Moving Average Convergence/Divergence (MACD) is 2/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 0/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the RTA Laboratuvarlari Biyolojik price going down in the near term. -2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for RTA Laboratuvarlari Biyolojik. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the RTA Laboratuvarlari Biyolojik price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
RTA Laboratuvarlari Biyolojik Daily Moving Average Convergence/Divergence (MACD) ChartRTA Laboratuvarlari Biyolojik Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of RTA Laboratuvarlari Biyolojik. The current adx is 36.40.

The long score for the Directional Movement Index (DMI) is 3/7.
The longshort score for the Directional Movement Index (DMI) is 3/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy RTA Laboratuvarlari Biyolojik shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX > 25 && ADX trending down: The ADX is above 25 and indicates a strong bullish trend. The ADX is declining, the bullish trend is weakening. Could be a potential reversal to the downside. +2
RTA Laboratuvarlari Biyolojik Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of RTA Laboratuvarlari Biyolojik. The current sar is 3.28.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
RTA Laboratuvarlari Biyolojik Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of RTA Laboratuvarlari Biyolojik. The current rsi is 53.77. The current phase is Continuation in bull market.

The long score for the Relative Strength Index (RSI) is 3/13.
The longshort score for the Relative Strength Index (RSI) is 2/(-13 +13).

  • Continuation in bull market: Uptrend continues after a consolidation or pullback. Hold or add to existing positions.
  • Trending down: The RSI is trending down. -1
RTA Laboratuvarlari Biyolojik Daily Relative Strength Index (RSI) ChartRTA Laboratuvarlari Biyolojik Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of RTA Laboratuvarlari Biyolojik. The current phase is Continuation in bull market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 2/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the RTA Laboratuvarlari Biyolojik price going up in the near term. +2
  • Trending down: The STOCH %K is trending down. -1
RTA Laboratuvarlari Biyolojik Daily Stochastic Oscillator ChartRTA Laboratuvarlari Biyolojik Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of RTA Laboratuvarlari Biyolojik. The current cci is 13.03.

RTA Laboratuvarlari Biyolojik Daily Commodity Channel Index (CCI) ChartRTA Laboratuvarlari Biyolojik Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of RTA Laboratuvarlari Biyolojik. The current cmo is 7.05840571.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
RTA Laboratuvarlari Biyolojik Daily Chande Momentum Oscillator (CMO) ChartRTA Laboratuvarlari Biyolojik Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of RTA Laboratuvarlari Biyolojik. The current willr is -44.15584416.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that RTA Laboratuvarlari Biyolojik is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
RTA Laboratuvarlari Biyolojik Daily Williams %R ChartRTA Laboratuvarlari Biyolojik Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of RTA Laboratuvarlari Biyolojik.

RTA Laboratuvarlari Biyolojik Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of RTA Laboratuvarlari Biyolojik. The current atr is 0.19054612.

RTA Laboratuvarlari Biyolojik Daily Average True Range (ATR) ChartRTA Laboratuvarlari Biyolojik Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of RTA Laboratuvarlari Biyolojik. The current obv is 2,767,055,999.

RTA Laboratuvarlari Biyolojik Daily On-Balance Volume (OBV) ChartRTA Laboratuvarlari Biyolojik Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of RTA Laboratuvarlari Biyolojik. The current mfi is 72.37.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
RTA Laboratuvarlari Biyolojik Daily Money Flow Index (MFI) ChartRTA Laboratuvarlari Biyolojik Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for RTA Laboratuvarlari Biyolojik.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2025-04-29MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-04-30DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2025-05-02DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-05-05MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2025-05-07STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-08CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-05-12STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-05-14SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2025-05-15STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-16STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-21STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-05-22MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2025-05-23WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-05-26STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-27STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-05-28SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-05-30DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-06-05DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2025-06-10CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-06-11MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2025-06-12STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-06-13MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-06-16STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-18STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-06-19BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-06-23BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-06-24STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-06-25DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-06-26MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2025-06-27STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-06-30STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-07-03WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-07-07STOCH LONG EXITThe %K line crosses below the %D line.
2025-07-09CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-07-10STOCH SHORT EXITThe %K line crosses above the %D line.
2025-07-11STOCH LONG EXITThe %K line crosses below the %D line.
2025-07-14STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-07-16STOCH LONG EXITThe %K line crosses below the %D line.
2025-07-17STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-07-18CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-07-23STOCH LONG EXITThe %K line crosses below the %D line.
2025-07-24STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2025-07-25STOCH LONG EXITThe %K line crosses below the %D line.
2025-07-28STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-07-29STOCH LONG EXITThe %K line crosses below the %D line.
2025-07-31STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-08-01CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-08-04STOCH LONG EXITThe %K line crosses below the %D line.
2025-08-05STOCH SHORT EXITThe %K line crosses above the %D line.
2025-08-06STOCH LONG EXITThe %K line crosses below the %D line.
2025-08-07STOCH SHORT EXITThe %K line crosses above the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-08-11STOCH LONG EXITThe %K line crosses below the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-08-13RSI SHORT ENTRY LONG CLOSE70 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-08-14SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2025-08-15STOCH SHORT EXITThe %K line crosses above the %D line.
2025-08-18SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-08-20STOCH LONG EXITThe %K line crosses below the %D line.
2025-08-21STOCH SHORT EXITThe %K line crosses above the %D line.
2025-08-22MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2025-08-25MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2025-08-26CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-08-27MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2025-08-29STOCH SHORT EXITThe %K line crosses above the %D line.
2025-09-01MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-09-02MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-09-03SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-09-04STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-09-05MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2025-09-08MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-09-09SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-09-10CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-09-11DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-09-12STOCH SHORT EXITThe %K line crosses above the %D line.
2025-09-15DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2025-09-16CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-09-17SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.

6.3. Candlestick Patterns

RTA Laboratuvarlari Biyolojik Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of RTA Laboratuvarlari Biyolojik based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5053.767
Ma 20Greater thanMa 503.706
Ma 50Greater thanMa 1003.446
Ma 100Greater thanMa 2003.179
OpenGreater thanClose3.750
Total4/5 (80.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of RTA Laboratuvarlari Biyolojik with someone you think should read this too:
  • Are you bullish or bearish on RTA Laboratuvarlari Biyolojik? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about RTA Laboratuvarlari Biyolojik? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about RTA Laboratuvarlari Biyolojik

I send you an email if I find something interesting about RTA Laboratuvarlari Biyolojik.


Comments

How you think about this?

Leave a comment

Stay informed about RTA Laboratuvarlari Biyolojik.

Receive notifications about RTA Laboratuvarlari Biyolojik in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.